Artificial intelligence is on track to significantly change the health care industry.

AI is already being used in labs and hospitals to speed up clinical trials.

The average clinical trial process takes years to complete, costs hundreds of millions — if not billions— of dollars, and only 14 percent of drugs that enter clinical trials will get approval from the Food and Drug Administration, according to an MIT Sloan study published in 2018.

AI is helping companies and organizations use software that enables faster and more accurate collection of data, Dave Anderson, a spokesperson for AI software company Dynatrace, told FOX Business.

HOW ARTIFICIAL INTELLIGENCE IS SHAPING THE FUTURE OF SOCIETY

Machine-learning technology can accelerate time-to-market speeds, or the amount of time it takes between the conception of a product idea and the sale of that product, for vaccines and therapeutic drugs by up to 300 percent, Anderson said.

Typical drug experiments usually require microscopy snapshots of every reaction that happens when a cell representing a certain disease or illness is exposed to a number of different compounds; these trials can generate hundreds of millions of snapshots.

AI IDENTIFIED CORONAVIRUS BEFORE IT SPREAD. HERE'S HOW IT CAN CONTAIN FUTURE CONTAGIOUS VIRUSES

By using AI, scientists can predict how cells will react based on recycled snapshots rather than take new snapshots for every different cell-compound reaction, according to a blog post from Johnson & Johnson, which is currently developing a coronavirus vaccine. The blog post noted that AI can make the drug discovery process 250 times more efficient.

Dynatrace recently partnered with global health care company ERT, which develops software for clinical trials, to help build its software development and IT operations (DevOps) processes.

"[ERT] went from releasing a new application every six weeks to every two weeks," Anderson told FOX Business.

J&J BEGINS CLINICAL TRIAL OF SINGLE-DOSE CORONAVIRUS VACCINE

In the past, he said, when problems within clinical trials occured, teams would have to look across their infrastructure and applications to find out what causes problems, which "can take teams offline for a significant amount of time."

AI technology essentially does three things for the clinical trial process: Makes it faster, more reliable and more secure, enabling researchers to allocate their time on the most important aspects of the trial that require human attention, Anderson explained.

He added that an AI system can quickly determine which line of code or device has caused a problem within a clinical trial when it occurs so researchers can focus their time and effort on other matters.